CLINICAL_TRIALS
trial_result
· 2017-05-03
Clinical Trial Update: Lithium for Low-Grade Neuroendocrine Tumors [Phase 2]
Summary
Phase 2 clinical trial evaluating lithium for low-grade neuroendocrine tumors has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Neuroendocrine Tumors | Phase 2 | Status: COMPLETED | Results posted: 2017-05-03